Page last updated: 2024-11-07

prednisone and Myasthenic Syndromes, Congenital

prednisone has been researched along with Myasthenic Syndromes, Congenital in 1 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Myasthenic Syndromes, Congenital: A heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the NEUROMUSCULAR JUNCTION. This includes presynaptic, synaptic, and postsynaptic disorders (that are not of autoimmune origin). The majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor (RECEPTORS, NICOTINIC) on the postsynaptic surface of the junction. (From Arch Neurol 1999 Feb;56(2):163-7)

Research Excerpts

ExcerptRelevanceReference
"Myasthenia gravis is a life-threatening disease as evidenced by the death of one of our patients."1.31The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children. ( Buncic, JR; Mullaney, P; Smith, R; Vajsar, J, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mullaney, P1
Vajsar, J1
Smith, R1
Buncic, JR1

Other Studies

1 other study available for prednisone and Myasthenic Syndromes, Congenital

ArticleYear
The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Ophthalmology, 2000, Volume: 107, Issue:3

    Topics: Adolescent; Blepharoptosis; Child; Child, Preschool; Cholinesterase Inhibitors; Disease Progression;

2000